The odds of receiving first-line (FL) antibiotic therapy at pediatric urgent care centers (PUCs) were lower in White children ...

Company Expects to Announce VAX-31 Infant Study Topline Safety, Tolerability and Immunogenicity Data from Primary ...

2 He also encountered difficulties isolating pure cultures from liquid media, which inspired him to develop solid media that enabled the isolation of specific bacterial strains. Koch combated multiple ...

Acute otitis media (AOM) is common in infants and children ... Moreover, as Streptococcus pneumoniae is one of the leading AOM bacterial pathogens and it is well known that influenza virus ...

In infants, it was designed to cover approximately 94% of IPD and approximately 86% of acute otitis media in children under five years of age in the United States. Vaxcyte is a vaccine innovation ...

Acute Bacterial Otitis Media Persistent/Treatment Failure: Children - IM/IV 50 mg/kg/ IM or IV (not to exceed 1 gram) daily for 3 days. Pelvic Inflammatory Disease (mild to moderate): Adults - IM ...

Young children with otitis media may pull on their ear and/or be feverish, fussy, and have difficulty eating and sleeping. They may also vomit or have diarrhea. Mild ear infections may not require ...

Although neither nasopharyngeal nor throat cultures have been a useful guide to recommendations for the treatment of specific patients with AOM or acute bacterial sinusitis, they may be useful on ...

Company Expects to Announce VAX-31 Infant Study Topline Safety, Tolerability and Immunogenicity Data from Primary Immunization Series in Mid-2026, Followed by Topline Data from the Booster Dose Approx ...